Myeloid Tumor Panel NGS Genetic DNA Test - $500 USA Price | Comprehensive Cancer Genetic Testing in USA
Lung Cancer Mutation Panel Test - $526 USA | Comprehensive Genetic Testing for Lung Cancer Treatment Lung Cancer Mutation Panel Test Original price was: $750.Current price is: $526.
NRAS Gene Colorectal Cancer Hereditary NGS DNA Test - $500 USA | Comprehensive Genetic Screening for Hereditary Cancer Risk NRAS Gene Colorectal Cancer Hereditary NGS Genetic DNA Test Original price was: $700.Current price is: $500.
Sale!

Myeloid Tumor Panel NGS Genetic DNA Test

Original price was: $750.Current price is: $500.

-33%

The Myeloid Tumor Panel NGS Genetic DNA Test is a comprehensive diagnostic tool that utilizes next-generation sequencing technology to analyze 35+ genes associated with myeloid cancers. This advanced test provides crucial genetic information for patients with suspected or diagnosed myeloid malignancies, helping guide personalized treatment decisions. By detecting specific mutations in genes like FLT3, IDH1/2, JAK2, and TP53, the test enables oncologists to select targeted therapies and monitor treatment response. Results are typically available within 3-4 weeks from blood or DNA samples. The test is priced at $500 USD (discounted from $750) and includes genetic counseling to help interpret results and understand family implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Myeloid Tumor Panel NGS Genetic DNA Test

Comprehensive Genetic Analysis for Myeloid Cancers

The Myeloid Tumor Panel NGS Genetic DNA Test represents a cutting-edge approach to cancer diagnostics, utilizing next-generation sequencing (NGS) technology to provide detailed genetic insights into myeloid malignancies. This comprehensive panel examines over 35 genes specifically associated with myeloid cancers, offering clinicians and patients unprecedented information for personalized treatment planning and disease management.

What This Advanced Test Measures

Our Myeloid Tumor Panel employs sophisticated NGS technology to detect mutations across a comprehensive set of genes critical to myeloid cancer development and progression. The test analyzes:

  • Epigenetic Regulators: ASXL1, DNMT3A, EZH2, TET2
  • Signaling Pathway Genes: FLT3, JAK2, KIT, KRAS, NRAS, PTPN11
  • Tumor Suppressors: TP53, CDKN2A, NF1, PHF6
  • Transcription Factors: CEBPA, GATA2, RUNX1, WT1
  • Metabolic Enzymes: IDH1, IDH2
  • Spliceosome Components: SF3B1, SRSF2, U2AF1
  • Cohesin Complex Genes: RAD21, SMC1A, SMC3, STAG2

Who Should Consider This Genetic Test

This comprehensive myeloid panel is particularly valuable for individuals experiencing:

  • Unexplained fatigue, weakness, or persistent infections
  • Abnormal bleeding or bruising tendencies
  • Enlarged lymph nodes, spleen, or liver
  • Unexplained weight loss or night sweats
  • Bone pain or joint discomfort
  • Family history of myeloid cancers or blood disorders
  • Recent diagnosis of myelodysplastic syndromes (MDS)
  • Suspected acute myeloid leukemia (AML) or myeloproliferative neoplasms

Clinical Benefits and Applications

The Myeloid Tumor Panel provides numerous clinical advantages:

  • Personalized Treatment Selection: Identifies specific mutations that respond to targeted therapies
  • Prognostic Information: Helps determine disease aggressiveness and likely progression
  • Treatment Monitoring: Tracks genetic changes during therapy to assess response
  • Minimal Residual Disease Detection: Identifies low levels of cancer cells after treatment
  • Family Risk Assessment: Provides information about potential hereditary cancer risks

Understanding Your Test Results

Your comprehensive genetic report will include detailed information about detected mutations, their clinical significance, and potential therapeutic implications. Our genetic counseling team will help you understand:

  • Mutation Classification: Pathogenic, likely pathogenic, or variants of uncertain significance
  • Therapeutic Implications: FDA-approved targeted therapies matching your genetic profile
  • Clinical Trial Eligibility: Potential participation in cutting-edge research studies
  • Prognostic Significance: How specific mutations may impact disease course
  • Follow-up Recommendations: Additional testing or monitoring suggestions

Test Pricing and Availability

Test Component Price (USD)
Myeloid Tumor Panel NGS Genetic DNA Test $750
Discount Price $500

Turnaround Time: 3 to 4 weeks
Sample Type: Blood, Extracted DNA, or One drop Blood on FTA Card

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures easy access to this advanced genetic testing.

Pre-Test Preparation

Before your test, we recommend:

  • Providing complete clinical history relevant to myeloid conditions
  • Participating in a genetic counseling session to discuss family history
  • Completing a pedigree chart documenting affected family members
  • Discussing testing implications with your oncology team

Take Control of Your Cancer Journey

Don’t leave your treatment decisions to chance. The Myeloid Tumor Panel NGS Genetic DNA Test provides the genetic intelligence needed for informed, personalized cancer care. Our team of genetic specialists and oncology experts are ready to support you through every step of the testing process.

Ready to schedule your test? Call us today at +1(267) 388-9828 or book your appointment online. Take the first step toward personalized cancer care with comprehensive genetic insights.

SKU: 2aec405d4b59 Category:

Related products